| Source: |
| Type: tumour-suppressor miRNA |
| miR-200c studied particularly in the regulation of epithelial-to-mesenchymal transition (EMT) and cancer metastasis. miR-200c is a member of the miR-200 family, which includes miR-200a, miR-200b, and miR-200c. These miRNAs are known to play a crucial role in maintaining epithelial cell identity and suppressing EMT, a process by which epithelial cells acquire a mesenchymal phenotype and become more migratory and invasive. miR-200c has been shown to target several genes involved in EMT and cancer progression, including: ZEB1 and ZEB2, transcription factors that promote EMT and cancer metastasis. TGF-β, a cytokine that promotes EMT and cancer progression. Vimentin, a protein that is highly expressed in mesenchymal cells and is associated with cancer metastasis. The overexpression of miR-200c has been shown to inhibit EMT and cancer metastasis in various types of cancer, including breast, lung, and ovarian cancer. Conversely, the downregulation of miR-200c has been associated with cancer progression and poor prognosis. Downregulated in: lung, CRC, GC, pancreatic, HCC (associated with poor prognosis). |
| Colorectal cancer is a broader term that encompasses both colon and rectal cancer. |
| 679- | EGCG, | 5-FU, | Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer |
| - | in-vitro, | CRC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:765 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid